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Hippo (Hpo) signaling plays a critical role in restricting tissue growth and organ size in both
invertebrate and vertebrate animals. However, how the Hpo kinase is regulated during development
has not been clearly understood. Using a Bimolecular Fluorescence Complementation assay, we have
investigated the functional signiﬁcance of Hpo homo-dimer formation and subcellular localization in
living cells. We found that Hpo dimerization and membrane association are critical for its activation in
growth inhibition. As dimerization facilitates Hpo to access its binding partner, Hpo kinases in the
homo-dimer trans-phosphorylate each other to increase their enzymatic activity. Moreover, loss- and
gain-of-function studies indicate that upstream regulators, Expanded, Merlin and Kibra, play a critical
role in promoting Hpo dimerization as well as association to the cortical F-actin beneath the plasma
membrane. Enforced Hpo localization to the plasma membrane increases Hpo dimerization and
activity. Therefore, homo-dimerization and plasma membrane association are two important mechan-
isms for Hpo activation in growth control during animal development.
& 2013 Elsevier Inc. All rights reserved.Introduction
Tissue growth and organ size control is a fundamental issue in
developmental biology. Discovery of the evolutionarily conserved
Hippo (Hpo) signaling pathway provides an important entry point
to address this issue. The Hpo pathway regulates tissue growth
via restricting cell proliferation and growth and promoting
apoptosis (recently reviewed by Pan, 2010; Halder and Johnson,
2011; Zhao et al., 2011; Staley and Irvine, 2012).
Over the past decade, many factors have been identiﬁed to
operate through the Hpo pathway. The central part of the Hpo
pathway comprises a kinase cascade: the Ste20-like kinase Hpo
(Harvey et al., 2003; Jia et al., 2003; Pantalacci et al., 2003; Udan
et al., 2003; Wu et al., 2003), the NDR family protein kinase Warts
(Wts) (Justice et al., 1995; Xu et al., 1995), the WWdomain scaffold
protein Salvador (Sav) (Kango-Singh et al., 2002; Tapon et al., 2002)
and Mob as tumor suppressor (Mats) (Lai et al., 2005). These
core components of Hpo pathway repress tissue growth largely by
phosphorylating and thereby inhibiting a growth-promotingll rights reserved.
Biochemistry and Molecular
sity Park, PA 16802, Unitedprotein Yorkie (Yki)/YAP (Dong et al., 2007; Wei et al., 2007;
Zhao et al., 2007; Hao et al., 2008; Oh and Irvine, 2008; Zhang et al.,
2008). Yki/YAP act through their binding partners such as Scal-
loped (Sd) transcription factor to regulate the expression of down-
stream target genes important for cell proliferation and apoptosis
(Goulev et al., 2008; Wu et al., 2008; Zhang et al., 2008; Zhao et al.,
2008).
For factors acting in the upstream of the Hpo pathway, they
could be classiﬁed into several clusters (reviewed by Grusche
et al., 2010): proteins that function via atypical cadherin trans-
membrane receptor, Fat (Silva et al., 2006); Kibra–Expanded–
Merlin complex, which provides a direct link from the apical
membrane to core components of the Hpo pathway (Hamaratoglu
et al., 2006; Baumgartner et al., 2010; Genevet et al., 2010; Yu
et al., 2010); several apical-basal polarity proteins, including Lgl,
aPKC, Crumb (Grzeschik et al., 2010); and kinase Tao-1 which
could directly phosphorylate Hpo (Boggiano et al., 2011; Poon
et al., 2011). Although the core components of Hpo pathway are
invariant and conserved from ﬂy to human, the upstream reg-
ulators are much more diverse and, in many cases, partially
redundant. These upstream factors regulate Hpo pathway via
complicated network and have been shown to exhibit spatial and
temporal speciﬁcity. Thus, understanding the mechanism by
which Hpo kinase is regulated is a key for us to learn how the
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during development.
Apical Ex–Mer–Kibra complex is uniquely identiﬁed as a plat-
form for signal integration among upstream molecules. However,
how these proteins transduce signal to Hpo core components are
still unknown. Ex and Mer locate at the sub-apical region in
Drosophila epithelia cells and are proposed to provide input into
the Hpo pathway. Kibra, which interacts with both Mer and Ex
serves as a linker between Mer and Ex. Several studies suggest
that the recruitment of the core complex to the apical membrane
is important for activation, but the mechanism by which the
Ex–Mer–Kibra complex activates the core complex is currently
unclear (recently reviewed by Boggiano and Fehon, 2012).
In this study, we show that dimerization is necessary for Hpo
trans-phosphorylation and activation. We further investigated the
subcellular localization of Hpo dimer and demonstrated that only
membrane targeted Hpo dimer has higher activity. Importantly,
we found that Ex–Mer–Kibra complex regulates Hpo activity by
inﬂuencing Hpo dimer formation and its association to the
cortical F-actin beneath the cell membrane. Therefore, homo-
dimerization and plasma membrane association are two mechan-
isms important for Hpo activation.Results
Hpo kinase dimerization is directly observed in living cells
The Hpo kinase plays an important role in growth inhibition
during animal development but how Hpo activity is regulated has
not been fully understood. To better investigate Hpo regulation in
living cells, we have applied the Bimolecular Fluorescence Com-
plementation (BiFC) technique to directly visualize protein–
protein interaction in developing tissues. In BiFC, a ﬂuorescent
protein Venus is split into Venus N-terminus (VN) and C-terminus
(VC) (Kerppola, 2006; Hu, 2009). These two polypeptides alone
cannot produce ﬂuorescent signal. When fused to two proteins A
and B separately, however, they may complement each other and
generate ﬂuorescence only if proteins A and B can interact
(Fig. 1A). In this work, the full-length Hpo protein is fused with
VN and VC, respectively. The Hpo BiFC assay was performed both
in Drosophila S2 cells and developing tissues. This assay allows a
direct observation of Hpo–Hpo interaction in living cells and
provides an opportunity to examine subcellular localization and
regulation of dimerized Hpo protein.
To visualize Hpo dimerization, HpoVC together with HpoVN
were transfected into S2 cells or expressed in transgenic ﬂies.
bFosVC was used as a negative control. We found that HpoVC and
HpoVN exhibited positive BiFC signal both in S2 cells (Fig. 1B) and
third-instar larva wing discs (Fig. 1D), whereas bFosVC and
HpoVN showed no BiFC signal (Fig. 1C and E), indicating the
speciﬁcity of the BiFC assay.
To investigate whether Venus-tagging disrupts Hpo protein
activity, we performed adult wing analysis. Driven by a wing-
speciﬁc Gal4 transcription activator,MS1096-Gal4, transgenic ﬂies
carrying HpoVC or HpoVN had their wings greatly reduced in size
similar to that of Hpo transgenic ﬂies free of Venus-tagging
(Fig. S1) (e.g. Wu et al., 2003). Thus, Venus-tagging does not
interfere with Hpo activity in growth inhibition.
Hpo dimerization is necessary for its trans-phosphorylation
and activation, but such phosphorlylation is not required for Hpo
dimer formation
During the last stage of our work, Jin et al. (2012) showed
that Hpo activation can be mediated by homo-dimerization.Inter-molecular interaction between Hpo proteins is mediated by
two distinct mechanisms, one that uses the N-terminal region
including the kinase domain and the other one that is mediated
by the C-terminal SARAH domain (Jin et al., 2012). We also have
independently observed that Hpo without its SARAH domain was
still able to form homo-dimer in our BiFC assay (data not shown). To
test the idea that N-terminal and C-terminal regions are essential for
Hpo dimerization in living cells, HpoM242E,I634D was generated and
expressed in Drosophila S2 cells. While the Met242 to Glu mutation
is expected to abolish the N-terminal interaction, the Ile634 to Asp
mutation would prevent the C-terminal SARAH domain from
associating to each other (Jin et al., 2012). In our BiFC assay,
HpoM242E,I634D indeed failed to dimerize (compare Fig. 1G–G0 with
F–F0). Western blot analysis revealed that Hpo can no longer
undergo auto-phosphorylation and activation when it is unable to
dimerize (Fig. 1H).
To further test whether Hpo phosphorylation can only occur in
Hpo homo-dimer, we carried out cell sorting experiment (Fig. 1I).
HpoVC and HpoVN were co-transfected into S2 cells. After 40 h of
culture, the cells were sorted based on their production of BiFC
ﬂuorescence into BiFC-positive and BiFC-negative groups. These
two groups of cells were used to perform western blot analysis.
The results showed that BiFC-positive cells had more phosphory-
lated Hpo compared with BiFC-negative cells (Fig. 1J). This result
supports the idea that Hpo dimerization facilitates its autopho-
sphorylation and activation within the Hpo dimer complex.
We also investigated whether Hpo phosphorylation plays any
role in mediating its dimerization, we mutated two evolutionarily
conserved Hpo autophosphorylation sites (Glantschnig et al.,
2002), Thr189 and Thr195 to Ala or Glu. The Hpo mutants were
fused with VC or VN and were tested in the BiFC assay to detect
their interaction. We found that mutations of the phosphorylation
sites had no obvious inﬂuence on Hpo BiFC signal (Fig. S2),
suggesting that the phosphorylation is not a prerequisite for
Hpo dimerization.
Hpo inter-molecular phosphorylation was then examined. Hpo
kinase-dead (HpoK71R or HpoKD) mutation was co-transfected
with HpoT195E or HpoT195A. Although HpoT195E has partial kinase
activity, it cannot be detected by a phospho-speciﬁc Hpo antibody
towards Thr195 site, which is a residue essential for Hpo activity
(Glantschnig et al., 2002; Jin et al., 2012). Western blot data
showed that HpoKD could be phosphorylated by HpoT195E, but not
HpoT195A (Fig. 1K), suggesting that the phosphorylation normally
occurs between two interacting Hpo kinase proteins in the
complex.
Hpo kinase-dead mutant acts dominant-negatively due to its ability
to dimerize with wild-type Hpo protein
Unlike wild-type Hpo, HpoKD-VC and HpoKD-VN were unable
to produce BiFC signal, suggesting that they might fail to associate
with each other or they did associate but VN and VC failed to
complement (Fig. 2, compare A with B). However, HpoKD can
clearly interact with wild-type Hpo (Fig. 2C and D). This interac-
tion allows HpoKD to inactivate wild-type Hpo through HpoKD–
HpoWT complex formation, which would explain the dominant-
negative effect of the HpoKD protein (Fig. 2E–H).
Subcellular localization of the Hpo dimer is critical for its activity
To investigate where Hpo is localized at the subcellular level,
we immunostained wing discs of third-instar larva from wild-
type ﬂies or transgenic ﬂies. Both endogenous Hpo and a Flag-
tagged Hpo showed a portion of protein associated with plasma
membrane since it co-localizes with adherent junction marker
DE-cadherin, whereas most Hpo protein was detected in the
Fig. 1. Visualization of Hpo dimerization via the BiFC assay in living cells and impact of the dimerization on Hpo autophosphorylation and activation. (A) Diagram of the BiFC
assay. When proteins A and B form a complex, it may allow their fusion partners Venus N- and C-terminal polypeptides to complement to exhibit ﬂuorescence. (B–B0 & F–
F0) Direct visualization of Hpo homo-dimer in transiently transfected S2 cells. (C–C0) bFosVC/HpoVN was used as a negative control. (D–D0) Direct visualization of Hpo
homo-dimer in fruit ﬂy third-instar larval wing discs. en-Gal4 drives gene expression in the posterior compartment of wing discs (the compartment on the right side). (E–
E0) en-Gal4/UAS- bFosVC/HpoVN wing discs were used for a negative control. No BiFC signal was detected. (G–G0) Mutations of Met242 and Ile634 residues abolished Hpo
dimerization in S2 cells. (H) Hpo autophosphorylation at Thr195 cannot occur without dimerization. Hpo and HpoM242E,I634D were expressed in S2 cells. Through western
blot analysis, the total Hpo protein was detected with an Hpo antibody and activated Hpo protein was monitored by a phosphor-speciﬁc Hpo antibody (Thr195). (I–J) Cell
sorting experiment shows BiFC-positive cells had more phosphorylated Hpo compared to BiFC-negative cells. (K) HpoKD was trans-phosphorylated by HpoT195E and
endogenous Hpo proteins. After cotransfection of Flag-HpoKD/HA-HpoT195E-VC or Flag-HpoKD/HA-HpoT195A-VC to S2 cells, total protein extracts were used for western
blot and immune-staining with a Flag antibody to detect total Flag-HpoKD protein and a phospho-speciﬁc Hpo antibody (Thr195) to detect phosphorylated Flag-HpoKD
protein. BiFC signal is shown in green in all panels.
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dimer localization. Interestingly, a signiﬁcant fraction of Hpo
dimer was found to be associated with the cortical F-actin
cytoskeleton close to the plasma membrane in the apical region
(Fig. 3A–C; Fig. S3G–J). It can be also detected in the nucleus and
cytoplasm (Fig. 3D–I; Fig. S3G–N). Therefore, the Hpo dimer is
broadly distributed in major subcellular locations.
To further investigate how the Hpo dimer activity is correlated
with its subcellular localization, we did immunostaining against
phosphorylated Histone 3 (PH3) to highlight mitotic cells. Our
data shows that Hpo dimer was found in nuclei of all PH3-positivecells (n¼89) (Fig. 3D–I). Hpo dimer in the nucleus should be non-
functional in growth inhibition because the cells were actively
involved in proliferation. It is also possible that Hpo dimer is
directly involved in regulating some mitotic events.
Membrane targeting facilitates Hpo dimerization
and phosphorylation
We have previously found that the plasma membrane is an
important site for activation of a Hpo pathway component, Mats
(Ho et al., 2010). To test the idea that plasma membrane is a
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generated HpoVN/HpoVC containing a myristoylation (Myr) sig-
nal sequence in the Hpo N-terminus for membrane localization.
Interestingly, Myr-HpoVC and Myr-HpoVN failed to produce BiFC
signal (data not shown). However, Myr-HpoVN (or Myr-HpoVC)
could generate membrane-associated BiFC signal when it is
complexed with an unmyritoylated Hpo partner (Fig. 4A) and
Hpo dimer was found to be mostly associated with cortical F-actin
close to the plasma membrane (Fig. 4A0). Furthermore, BiFC assay
showed that Myr-HpoVN/HpoVC have higher BiFC efﬁciency than
HpoVN/HpoVC, suggesting that membrane-targeting facilitates
Hpo dimerization (Fig. 4B). Through western blot analysis, we
found that membrane-targeted Hpo (Myr-HpoVN) was more
phosphorylated than wild-type Hpo at Thr195 (Fig. 4C). Finally,
a luciferase reporter assay revealed that membrane-targeted Hpo
(Myr-HpoVN) was more potent to reduce Yki/Sd transcription
activity compared to unmyritoylated Hpo (Fig. 4D). Therefore, cell
membrane association is critical for Hpo to form dimer and
become activated.
Merlin, Expanded and Kibra act together to regulate Hpo subcellular
localization and dimerization
Mer, Ex and Kibra function together and act in a partially
redundant manner to regulate Hpo signaling (Hamaratoglu et al.,
2006; Baumgartner et al., 2010; Genevet et al., 2010; Yu et al.,
2010). However, how Hpo is regulated by these upstream reg-
ulators is not clearly understood. To investigate the hypothesis
that they regulate Hpo activity by inﬂuencing Hpo dimerization,
RNA interference (RNAi) treatment was done to knock down
endogenous Mer, Ex and Kibra. Western blot analysis indicates
that the RNAi was effective in reducing expression of these genes
dramatically (Fig. S4). Through these RNAi experiments, we found
that Hpo dimerization efﬁciency decreased when the expression
of Mer, Ex and Kibra proteins was reduced (Fig. 5A, left panel).In contrast, Hpo-Sav interaction was not dramatically inﬂuenced
by Mer–Ex–Kibra triple knocking-down (Fig. 5A, right panel).
Through a gain-of-function approach, we found that the Hpo BiFC
signal was increased by Mer and Ex co-expression (Fig. 5B, left
panel), whereas the Hpo-Sav BiFC signal did not show any
signiﬁcant change under the same condition (Fig. 5B, right panel).
These results suggest that Mer, Ex and Kibra act together to
facilitate Hpo dimer formation in living cells.
Furthermore, we tested the inﬂuence of Mer/Ex/Kibra complex
on Hpo dimer subcellular localization in S2 cells. We arbitrarily
classiﬁed the distribution of Hpo BiFC signal into three patterns
(membrane-associated, cytoplasm, and cytoplasmþnucleus)
(Fig. 5C). Then we examined the Hpo dimer distribution under
different genetic background. The results showed that when Mer,
Ex and Kibra were knocked down by RNAi, the portion of
membrane-associated Hpo dimer was decreased from 37% to
19% and cytoplasm/nucleus-localized Hpo dimer was increased
(Fig. 5D, n¼432). On the other hand, the membrane-associated
Hpo dimer was increased from 21% to 59% when Mer, Ex and
Kibra were over-expressed, whereas the nucleus/cytoplasm loca-
lized Hpo dimer was decreased (Fig. 5E, n¼523). Next, the Hpo
dimer distribution in developing tissues was examined. Com-
pared with wild-type control, we observed that more Hpo dimers
were localized to the nucleus when mer and ex were knocked
down by RNAi (Fig. 5, compare F–F0 with G–G0). These results
support the idea that Mer, Ex and Kibra facilitate Hpo membrane
association and dimerization.Discussion
The Drosophila Hpo kinase plays a key role in tissue growth
inhibition and organ size control, but how Hpo is regulated is still
not fully understood. In this study, we took advantage of direct
visualization of protein–protein interaction to observe Hpo
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Fig. 4. Membrane targeting facilitates Hpo dimerization and phosphorylation. (A–A0) Myr
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ﬂow cytometry, Hpo dimer formation was measured by BiFC levels and the BiFC s
phosphorylated at Thr195 than non-myristoylated Hpo. After transfection, expression
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Fig. 3. Subcellular localization of Hpo homo-dimer in developing tissues. (A) Hpo
dimer localization is shown by Hpo-Hpo BiFC (green) at the apical region of cells
in larval wing discs. (B) Phallotoxin was used to highlight the F-actin cytoskeleton
(red). (C) A fraction of Hpo dimer was found to associate with cotical F-actin near
the plasma membrane. (D–I) In the mitotic cells labeled by PH3 staining (red), Hpo
BiFC signal (green) was always found in the nucleus. DAPI staining highlighted the
nucleus (blue). Arrows pointed out one example. Expression of VN or VC-tagged
hpo transgenes was driven by en-Gal4 in the posterior compartment of late third-
instar larval wing discs.
Y. Deng et al. / Developmental Biology 375 (2013) 152–159156homo-dimerization and activation in living cells. We demonstrate
that Hpo can be activated by trans-phosphorylation upon homo-
dimer formation. Importantly, this mechanism is evolutionarily
conserved. Mammalian homologs of Hpo protein, Mst1 and Mst2
protein kinases, are activated through dimerization and autopho-
sphorylation in response to stress signaling (reviewed by de
Souza and Lindsay, 2004).
However, dimerization is not the only factor to drive Hpo
activation. In our study, we found that Hpo sub-cellular localiza-
tion also inﬂuences its activity. While Hpo dimer exists broadly in
both nucleus and cytoplasm, its nuclear form appears to be non-
functional or has low activity in inhibiting processes such as cell
proliferation (also see Jin et al., 2012). In contrary, mammalian
Mst1/2 proteins are cleaved through caspases for nuclear trans-
location and their nuclear forms are actively involved in promot-
ing apoptosis (reviewed by de Souza and Lindsay, 2004).
Moreover, a fraction of Hpo dimer is associated with cortical
F-actin beneath the plasma membrane. Such membrane associa-
tion should have a positive impact on Hpo dimerization, since
membrane-targeted Hpo showed higher efﬁciency of homo-dimer
formation. The functional importance of its membrane associa-
tion is supported by the fact that membrane-targeted Hpo
showed higher kinase activity and more potent in inhibiting the
transcription activity mediated by Yki and Sd proteins. Similarly, a
downstream component of the Hpo pathway, Mats, is constitu-
tively activated to restrict tissue growth and organ size when it is
targeted to cell membrane (Ho et al., 2010). Based on these
observations, it becomes clear that Hpo localization inﬂuences
its dimer formation. Hpo dimerization and its subcellular locali-
zation work together to regulate Hpo kinase activity.
While membrane-associated proteins that include Ex, Merlin and
Kibra act genetically upstream of Hpo (Hamaratoglu et al., 2006;H
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Y. Deng et al. / Developmental Biology 375 (2013) 152–159 157Baumgartner et al., 2010; Genevet et al., 2010; Yu et al., 2010), we
found that knock-down of Ex, Mer and Kibra function reduces Hpo
homo-dimerization and membrane association. Consistently, over-
expression of Ex, Mer and Kibra increases Hpo homo-dimerization
and membrane association. Therefore, our results validated a
hypothesis that these molecules play a critical role in membrane
recruitment and dimerization of the Hpo protein. Also supporting
this model, Hpo is known to interact with Ex (Formstecher et al.,
2005; Yu et al., 2010) as well as Kibra (Yu et al., 2010). Through cell
fractionation, the amount of Hpo protein associated with cellmembrane was reduced when the function of ex, mer and kibra
was knocked down in S2 cells (Yu et al., 2010).
Recently, the Tao-1 protein kinase has been shown to directly
activate Hpo via phosphorylation for growth suppression
(Boggiano et al., 2011; Poon et al., 2011). However, even without
utilizing additional enzymes, Hpo homo-dimerization appears
to be sufﬁcient to allow trans-phosphorylation to occur between
Hpo binding partners likely due to their proximity. Membrane-
associated upstream regulators, such as Mer, Ex and Kibra, help
recruit Hpo to cell membrane to locally increase Hpo concentration
Y. Deng et al. / Developmental Biology 375 (2013) 152–159158to promote Hpo dimerization, autophosphorylation and activation.
As mammalian Mst1 kinase activity can be also increased by
membrane recruitment (Praskova et al., 2004), cell membrane as
well as closely located cortical F-actin appear to be an evolutiona-
rily conserved site of action for Hpo activation for growth
inhibition.Materials and methods
DNA cloning, transgenes and drosophila genetics
A full-length hpo cDNA was ﬁrst cloned into pBiFC vectors
(Addgene) to make HA-hpoVC and Flag-hpoVN (also described as
hpoVC and hpoVN for simplicity). Myr-HA-hpoVC and Myr-Flag-
hpoVN were constructed following a strategy described in (Ho
et al., 2010). HA-sav-VC and Flag-savVN were also made. These
fusion constructs as well as bFosVC and bJunVN were then cloned
to a pUAST vector with attB sequence inserted upstream of the
UAS-binding sites. All hpo point mutations were generated by
PCR-based site-directed mutagenesis. An hpo kinase-dead (hpoKD)
construct was made by changing the codon for amino acid 71Lys
to Arg. Other constructs include hpoM242E,I634D, hpoT189A, hpoT195A,
hpoT189A,T195A, hpoT189E, hpoT195E, hpoT189E,T195E, with each of them
linked to VC and VN separately. All DNA constructs were veriﬁed
by sequencing. Primer information is available upon request.
To generate site-directed transgenic ﬂies (Bischof et al., 2007;
Fish et al., 2007), phiC31ﬂies were used to make transgenic lines
with insertions on the second chromosome (51C) or third chro-
mosome (86F). Transgenic lines generated in this project include
UAS-hpoVN, UAS-hpoKDVN and UAS-hpoKDVC. For UAS-hpoVC, UAS-
savVN, UAS-bfosVC and UAS-bjunVN, we established transgenic
lines after DNA injection done by Rainbow Transgenic Flies Inc.
C5-Gal4, en-Gal4 and MS1096-Gal4 are from the Blooming Droso-
phila Stock Center. RNAi lines, exRNAi (#109281) and merRNAi
(#7161), are from the Vienna Drosophila RNAi Center.
Cell culture, transfection, and RNAi analysis
S2Rþ cell were cultured in Drosophila Schneider’s Medium
(Sigma) with 10% fetal bovine serum in 24 1C incubator. Plasmid
transfection was carried out using Cellfectin II reagent (Invitro-
gen) according to Manufacturer’s instruction. The pAc-Gal4 con-
struct (Addgene) was co-transfected with all the pUAST
expression vectors. The plasmids used in this study including
pAc-HA-merlin, pAc-HA-expanded (Gift from Dr. George Halder),
pAc-kibra (Gift from Dr. Nicolas Tapon). The RNAi protocol with
the S2 cells was from the Drosophila RNAi Screening Center
(DRSC). The dsRNA design is from public DRSC screening data-
base. RNAi transfection was carried out using Qiagen’s Effectene
reagent (Qiagen) according to manufacturer’s instruction.
Flow cytometry, immunocytochemistry and microscopy
BiFC analysis assay: 40 h after transfection, S2Rþ cells were
resuspended following ﬂow cytometric analysis (Beckman Coulter
FC500). BiFC ﬂuorescence was normalized for expression by
analysis of HA-Hpo staining signal through ﬂow cytometry. Each
group of data was performed three times.
For general immunocytochemistry, late third-instar larval
imaginal discs were ﬁxed in PLP ﬁxative (2.5% paraformaldehyde,
0.075M lysine, 0.25% W/V Na-periodate). In order to maintain the
BiFC signal, the tissues were incubated with a primary antibody at
room temperature for 2 h, followed by incubation with a second-
ary antibody for 2 h at room temperature. Antibodies used in this
study include: anti-PH3 rabbit (1:100, Cell Signaling), anti-DE-cadherin rat (1:50), anti-HA mouse (1:100, Sigma), anti-Hpo rat
(1:200, gift from Dr. Nicolas Tapon), Alexa Fluor (AF) 568, AF594
(1:200), DAPI (1:2000, Invitrogen), phallotoxins (1:200, Invitro-
gen). Images were collected by sequential scanning using Olym-
pus Fluoview 300 and Olympus Fluoview 1000 Confocal Laser
Scanning Microscopes.
Luciferase assay
S2Rþ cells were cultured in 24-well plates. All the samples
were co-transfected with 10 ng of the copia-Renilla luciferase
reporter as a normalization control and 250 ng of 3xSd_luc (Gift
from Dr. Jin Jiang) ﬁreﬂy luciferase reporter using Cellfectin II.
50 ng of pAc-ykiV5, pUAST-HA-sd and pAc-Gal4 were used in each
well to promote the ﬁreﬂy Luciferase expression. 48 h incubation
after transfection, cell extracts were made and the Dual-
Luciferase measurements were performed using the Dual-GloTM
luciferase assay kit (Promega) according to the manufacturer’s
protocol.
Adult wing size analysis
Adult male ﬂy wings were collected and mounted onto glass
slides. Wing images were collected using a dissecting microscope
via the SPOT Basic Imaging software. The wing area in pixels was
measured using ImageJ software. The wing sizes were normalized
to wild-type wings.
Western blot analysis
Western blot was detected by running 10% SDS-PAGE, follow-
ing standard blotting and immune detection procedures. To
detect activated Hpo protein, a phospho-Thr195 speciﬁc Hpo
antibody was generated in rabbit (Genemed Synthesis, Inc.). The
antibodies used in this study include: anti-Hpo rabbit (1:2000, Dr.
Helen McNeill), anti-P-Thr195-Hpo rabbit (1:500), anti-Ex rabbit
(1:1000, Dr. George Halder), anti-a-Tubulin (1:2000, Sigma),
anti-HA mouse, anti-HA rabbit, anti-Flag rabbit, and anti-Myc
mouse antibodies.Acknowledgements
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